Board of Trustees
Robin L. Smith, MD, President and Chairman of the Board
Dr. Robin L. Smith is a leading global thought leader in the regenerative medicine industry, one of the fastest growing segments of modern-day medicine. With an M.D. from Yale University and an M.B.A. from the Wharton School of Business, Dr. Smith is the former CEO of the NeoStem family of companies, which she led from 2006 to 2015 and established as one of the preeminent healthcare brands focused on the development of cellular therapies. While leading NeoStem, Dr. Smith raised over $200 million, completing six acquisitions and one divestiture. Notably, she helped pioneer the company’s innovative business model, combining proprietary cell therapy development with a successful contract development and manufacturing organization, which provides these services broadly to companies working in the regenerative medicine industry. The company has won an array of industry awards and business recognition during her tenure, including a #1 ranking in the Tri-State region (for two years in a row), and #11 nationally, on Deloitte’s Technology Fast 500™, and Frost & Sullivan’s North American Cell Therapeutics Technology Innovation Leadership Award.
In 2008, Dr. Smith founded The Stem For Life Foundation (SFLF), a nonpartisan, 501(c)3 educational organization devoted to fostering global awareness of the potential for regenerative medicine to treat and cure a range of deadly diseases and debilitating medical conditions, as opposed to merely treating their symptoms. In 2010, in order to bring the charity’s mission to a global audience, Dr. Smith forged a historic, first-of-its-kind partnership with The Vatican. As part of this relationship, The Vatican and SFLF collaborate to create high-profile initiatives that help catalyze interest and development of cellular therapies that could ultimately reduce human suffering on a global scale.
Dr. Smith is well known as a thought leader in regenerative medicine and maintains a regular column on these topics for The Huffington Post. She is a winner of the 2014 Brava! Award, which recognizes top women business leaders in the Greater New York area. She was also a finalist for the 2014 EY Entrepreneur Of The Year award for the New York area, recognizing entrepreneurs who demonstrate excellence and success in the areas of innovation, financial performance and personal commitment to their businesses and communities.
In addition, Dr. Smith has extensive experience serving in executive and board level capacities for various medical enterprises and healthcare-based entities. She currently serves on the Board of Directors of Signal Genetics (NASDAQ: SGNL). In mid-2015, she joined the boards of MYnd Analytics and BioXCell. She also serves on the Board of Directors of the Science and Faith STOQ Foundation in Rome, as well as on the Capital Formation Committee of the Alliance for Regenerative Medicine. She previously served on the Board of Trustees of the NYU Langone Medical Center and is a past Chairman of the Board of Directors for the New York University Hospital for Joint Diseases.
As a business leader, entrepreneur, doctor and philanthropist, Dr. Smith is uniquely positioned to lead the global healthcare industry into the cellular future, where the cells of our bodies will stand as the foundation for a wide array of cures.
Dr. Max Gomez, Trustee
One of TV’s most respected medical journalists, Dr. Max Gomez has produced award-winning health and science segments for network stations in New York and Philadelphia. Dr. Max has reported for Dateline, Today Show and 48 Hours.
Over more than three decades, he’s earned nine Emmy Awards, three NY State Broadcaster’s Association awards and UPI’s “Best Documentary” award.
In addition to NYC’s ‘Excellence in Time of Crisis’ for his September 11 coverage, Dr. Max has been singled out nationally for special award recognition by the Leukemia and Lymphoma Society and The National Marfan Foundation. He was also named the American Health Foundation’s “Man of the Year.”
A noted moderator and speaker, Dr. Max is the regular moderator for Memorial Sloan-Kettering’s Cancer Smart public education series. He was also an organizer and moderator for two international conferences on adult stem cells hosted by and held at the Vatican.
Max also trains physicians nationally in public speaking and presentation, speaking to groups as diverse as the National Cancer Institute and the College of American Pathologists.
Max is the co-author of “Our Stem Cells – The Mysteries of Life and Secrets of Healing”, a layman’s guide to the medicine of the future, showcasing a wide array of emerging adult stem cell breakthroughs, including their ability to repair damaged hearts and organs, restore sight, kill cancer, cure diabetes, heal burns and stop the march of degenerative diseases, such as Alzheimer’s, multiple sclerosis and Lou Gehrig’s disease. Covering stem cell applications in everything from orthopedics to heart disease, cancer and HIV, it includes a special address by Pope Benedict XVI, urging increased support and awareness for advancements in adult stem cell research in order to alleviate human suffering.
Dr Max is also the co-author of “The Prostate Health Program: A Guide to Preventing and Controlling Prostate Cancer.” The 384-page book explains how an innovative program consisting of diet, exercise and lifestyle changes may help prevent prostate cancer.
Dr. Max currently serves on the following boards: American Heart Association, national and regional boards; Science Writers Fellowship at the Marine Biological Laboratory in Woods Hole, MA; Crohn’s and Colitis Foundation of America, Long Island Chapter; and The Partnership for After School Education, a city-wide group of 1,600 community-based programs that tutor and mentor students. He previously served as the past Chair of National Communications Committee for American heart Association, past Vice-chair of Princeton Alumni Weekly board and Chair of Communications Committee for the American Association for the Advancement of Science.
Dr. Max also mentors undergraduate journalism students, as well as medical students and physicians who are interested in medical journalism. He is an honors graduate of Princeton University and the Wake Forest University School of Medicine (PhD in Neuroscience) and was an NIH postdoctoral fellow at Rockefeller University.
Steven G. Martin
Mr. Martin is the Managing Member and a founder of Aspire Capital Fund, LLC a Chicago-based investment fund started in 2010 which has invested over $250 million in small emerging growth companies. Aspire Capital is focused on investing in life science companies and promoting early stage clinical development of cellular therapies and regenerative medicine. Mr. Martin has thirty years of legal and financing experience and has funded or committed to fund over $1.5 billion in investments. During his career, Mr. Martin has invested in hundreds of development-stage companies and many emerging cell therapy companies catalyzing their growth.
In 1999, Mr. Martin also founded Fusion Capital, a private investment fund which over ten years funded small emerging growth companies with a focus on life science companies. Prior to Fusion Capital, Mr. Martin was a partner at the Chicago law firm of Katten Muchin Rosenman LLP. As an attorney, Mr. Martin represented institutional investors and companies in highly complex financings as well as venture capital and private equity transactions.
Mr. Martin received his Juris Doctor degree with honors from Northwestern University School of Law. Mr. Martin graduated with high honors from the University of Michigan with a Bachelors of Business Administration, concentrating in finance.